May 18 (Reuters) - Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main goal in a late-stage trial, potentially offering a convenient alternative ...
The new treatment could hit the market as early as 2027.
By Dennis Thompson HealthDay ReporterWEDNESDAY, May 20, 2026 (HealthDay News) — Some people with sleep apnea might be able to shed their CPAP masks in favor of a once-nightly pill, a new study says.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results